May 15, 2020 / 1:20 AM / 10 days ago

BRIEF-Southern Shuanglin Bio-Pharmacy Plans To Buy Harbin-Based Bio-Pharmaceutical Firm Via Cash, Share Issue

May 15 (Reuters) - Southern Shuanglin Bio-Pharmacy Co Ltd :

* SAYS IT PLANS TO BUY HARBIN-BASED BIO-PHARMACEUTICAL FIRM PAFC VIA CASH, SHARE ISSUE

* SAYS IT AIMS TO RAISE UP TO 1.6 BILLION YUAN ($225.56 million) IN PRIVATE PLACEMENT OF SHARES TO FUND THE ACQUISITION, PROJECTS AND REPAY DEBTS

* SAYS TRADING IN SHARES TO RESUME ON MAY 15 Source text in Chinese: bit.ly/3bxtX3j ; bit.ly/3dM5fNZ Further company coverage: ($1 = 7.0935 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below